Dr. James Yu Chang Shen, MD

Dr. Shen practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Shen's NPI, 1063792265, was assigned on August 19, 2011. Dr. Shen graduated from University of Pittsburgh School of Medicine in 2010. Dr. Shen holds California license A124341.

Dr. Shen's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Shen's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Shen is also affiliated with Huntington Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Shen to 1 more hospital, 2 home health agencies, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shen practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shen's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shen is board certified in hematology by the American Board of Internal Medicine. Dr. Shen is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Shen treats.

CMS data shows 106,463 Medicare services from Dr. Shen across 52 procedure codes in 2024, for 538 Medicare patients. Medicare paid $1,509,655 for them.

CMS counts 538 Medicare patients who saw Dr. Shen in 2024. The largest group is 65 to 74, with 231 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shen's median patient age at 72, with 51% women.

In 2024, Dr. Shen wrote 1,742 Medicare Part D claims for 212 patients. 74% of them were for generic drugs. CMS names the drug for 1,414 of them, across 56 drugs with 11 or more claims each, at $4,418,272 in total drug cost. In 2023, CMS named 1,249 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Shen for performance year 2024, reported as part of a group. Dr. Shen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shen as offering telehealth.

Dmand AI links 4 papers to Dr. Shen, published from 2021 to 2022. Dr. Shen's most frequent co-authors are Camille Adeimy, MD, Mihaela Carmen Cristea, MD and Stacy Wang Gray, MD.

Dmand AI links Dr. Shen to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Colonic Neoplasms and Colorectal Neoplasms.

CMS Open Payments shows 158 general payments to Dr. Shen from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $9,260.

Dr. Shen graduated from University of Pittsburgh School of Medicine in 2010. Dr. Shen is a member of ASCO and ASH.

Dr. Shen is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.